Last week, Thomson Reuters said that it had purchased Entagen, a privately-owned informatics company that offers semantic search and navigation software and custom development services to pharmaceutical, biotechnology, and laboratory automation companies, for an undisclosed amount.

Joseph Donahue, senior vice president for Thomson Reuters' life science business, told BioInform that all eight Entagen employees will join Thomson Reuters staff with current CEO Chris Bouton joining the company's life science leadership team.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.